Assistant Professor; Joint Faculty, Department of Microbiology and Immunology
Division of Hematology
Area of Interest
The Vincent Lab works in the areas of systems tumor immunology and immunogenomics, to better understand anti-tumor immunity and translate this into curative immunotherapy strategies.
Awards and Honors
- Biological and Biomedical Sciences Faculty Mentor Award, UNC-Chapel Hill, 2022
- Invited speaker, Immuno-Oncology Young Investigators Forum, 2016
- Pope Clinical Fellow Award, Lineberger Comprehensive Cancer Center, 2015
- Outstanding Fellow Award, North Carolina Oncology Association, 2015
- Invited speaker, Illumina Users Group Meeting, 2015
- Outstanding Abstract Travel Award, American Society of Hematology, 2013
- Farmer Award for Compassion in Medicine, UNC Hospitals Department of Internal Medicine, 2010
- David A. Ontjes Outstanding Intern Award, UNC Hospitals Department of Internal Medicine, 2010
- Competitive Selection to ABIM Research Track, UNC Department of Hematology/Oncology, 2009
- John B. Graham Medical Student Research Society, University of North Carolina, 2008
- Harold C. Pillsbury Basic Science Award, University of North Carolina School of Medicine, 2008
- Holderness Research Fellowship, University of North Carolina School of Medicine, 2005
News and Stories
Loved ones battling cancer inspire donor’s gift
After seeing friends and family members struggle with cancer and tired of feeling helpless, Betsy Jordan decided to do something about it by making a gift to support innovative research.
A patient’s decision adds immeasurably to knowledge about how to treat lung cancer
Chad Pecot, MD, and colleagues used biospecimens from a patient just after he succumbed to lung cancer to unravel how a KRAS mutation developed resistance to a treatment that had initially proved effective.
Susan G. Komen announces $1.5 million in grants for metastatic breast cancer research
Susan G. Komen has awarded three grants in support of metastatic breast cancer research as part of a collaboration between Komen, UNC Lineberger and Duke Cancer Institute, called the Susan G. Komen Metastatic Breast Cancer Collaborative Research Initiative.
Immunotherapy after high-dose chemotherapy leads to favorable outcomes in acute myeloid leukemia
Josh Zeidner, MD, Jon Serody, MD, and colleagues report clinical trial outcomes that benefited patients with resistant or relapsed acute myeloid leukemia.